S. Ali

461 total citations
14 papers, 367 citations indexed

About

S. Ali is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, S. Ali has authored 14 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Organic Chemistry. Recurrent topics in S. Ali's work include MicroRNA in disease regulation (5 papers), Computational Drug Discovery Methods (3 papers) and Click Chemistry and Applications (2 papers). S. Ali is often cited by papers focused on MicroRNA in disease regulation (5 papers), Computational Drug Discovery Methods (3 papers) and Click Chemistry and Applications (2 papers). S. Ali collaborates with scholars based in United States, India and United Kingdom. S. Ali's co-authors include F. H. Sarkar, P. A. Philip, Sean K. Sethi, Husain A. Saleh, Ashhar Ali, Seema Sethi, Rainer Schobert, Susanne Seibt, Bernhard Biersack and Aamir Ahmad and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

S. Ali

11 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Ali United States	6	283	230	77	27	22	14	367
Farzad Rahmani Iran	10	229 0.8×	148 0.6×	66 0.9×	15 0.6×	20 0.9×	15	375
Archana De United States	9	302 1.1×	115 0.5×	95 1.2×	21 0.8×	27 1.2×	18	454
Changtian Yin China	8	309 1.1×	138 0.6×	68 0.9×	24 0.9×	20 0.9×	11	412
Chunle Zhao China	10	246 0.9×	142 0.6×	86 1.1×	19 0.7×	23 1.0×	13	399
Hongbing Ma China	11	328 1.2×	224 1.0×	50 0.6×	72 2.7×	9 0.4×	20	458
Yiman Liu China	3	306 1.1×	207 0.9×	45 0.6×	16 0.6×	24 1.1×	6	405
Yi Yuan China	9	311 1.1×	167 0.7×	86 1.1×	16 0.6×	18 0.8×	17	466
Shi-Bing Su China	10	249 0.9×	113 0.5×	82 1.1×	16 0.6×	11 0.5×	10	428

Countries citing papers authored by S. Ali

Since Specialization

Citations

This map shows the geographic impact of S. Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ali more than expected).

Fields of papers citing papers by S. Ali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ali. The network helps show where S. Ali may publish in the future.

Co-authorship network of co-authors of S. Ali

This figure shows the co-authorship network connecting the top 25 collaborators of S. Ali. A scholar is included among the top collaborators of S. Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Ali. S. Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ali, S., et al.. (2025). Harnessing the synergistic potential of EGCG and camptothecin against skin melanoma: a computational and experimental approach. Molecular Diversity. 30(1). 1553–1568.

Ali, S., et al.. (2024). Network pharmacology combined with molecular docking and experimental verification to elucidate the effect of flavan-3-ols and aromatic resin on anxiety. Scientific Reports. 14(1). 9799–9799. 13 indexed citations

Ali, S., et al.. (2024). Integrated network pharmacology analysis and experimental validation to investigate the mechanism of Flavan-3-ols and aromatic resins in depression. Metabolic Brain Disease. 39(5). 763–782.

Ali, S., et al.. (2024). Design and Synthesis of (2,3-dichloro-4-(3-(substituted Phenyl)acryloyl) phenoxy) Substituted Carboxylic Acid as Potent Glutathione-s-transferase Inhibitors, Anti-breast-cancer Agents and Enhancing Therapeutic Efficacy of Anticancer Agents. Medicinal Chemistry. 21(4). 319–330.

Chu, L.W., Karen Kelly, David R. Gandara, et al.. (2018). P3.13-26 Outcomes of Patients with Metastatic Lung Cancer Presented in a Multidisciplinary Molecular Tumor Board. Journal of Thoracic Oncology. 13(10). S986–S986. 1 indexed citations

Ward, Christopher M., et al.. (2016). MiRNA-200b Inhibits Epithelial-Mesenchymal Transition in TGF-b1 Induced Human Bronchial Epithelial Cells.. American Journal of Transplantation. 1 indexed citations

Sethi, Seema, S. Ali, & F. H. Sarkar. (2014). MicroRNAs in personalized cancer therapy. Clinical Genetics. 86(1). 68–73. 34 indexed citations

Ali, Ashhar, et al.. (2012). Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. Carcinogenesis. 33(8). 1563–1571. 80 indexed citations

Ahmad, Aamir, Sanila H. Sarkar, Amro Aboukameel, et al.. (2012). Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling. Carcinogenesis. 33(12). 2450–2456. 63 indexed citations

10.

Ali, S., Husain A. Saleh, Sean K. Sethi, F. H. Sarkar, & P. A. Philip. (2012). MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. British Journal of Cancer. 107(8). 1354–1360. 100 indexed citations

11.

Kong, Dong, E. Heath, Wei Chen, et al.. (2012). Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.. PubMed. 4(1). 102–103. 70 indexed citations

12.

Patel, Mehul, Supriya K. Saha, S. Ali, et al.. (2007). Comparative analysis of bone marrow (BM) micrometastasis (M) with sentinel lymph node (SLN) status in early breast cancer (BRCa). Journal of Clinical Oncology. 25(18_suppl). 508–508. 1 indexed citations

13.

Ali, S., et al.. (2006). Sensitization of pancreatic cancer cells to ApoG2 induced killing by curcumin. Journal of Clinical Oncology. 24(18_suppl). 13152–13152. 1 indexed citations

14.

Gadgeel, Shirish M., S. Ali, P. A. Philip, Agnieszka Woźniak, & F. H. Sarkar. (2006). Dual blockade of epidermal growth factor receptor (EGFR) and cyclooxygenase 2 (COX 2) may be dependent upon the EGFR mutational status in non-small cell lung cancer (NSCLC) cell lines. Journal of Clinical Oncology. 24(18_suppl). 7170–7170. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farzad Rahmani Breakdown of academic impact, for papers by Archana De Breakdown of academic impact, for papers by Changtian Yin Breakdown of academic impact, for papers by Chunle Zhao Breakdown of academic impact, for papers by Hongbing Ma Breakdown of academic impact, for papers by Yiman Liu Breakdown of academic impact, for papers by Yi Yuan Breakdown of academic impact, for papers by Shi-Bing Su